Bayer, Glaxo Find Steps Difficult Toward Better Margins In Consumer Product Space
This article was originally published in The Tan Sheet
Executive Summary
Glaxo and Bayer report second-quarter growth in consumer segment sales driven largely by the new parts of the businesses. GSK’s earnings report is its first since taking the helm of a consumer product JV with Novartis AG; Bayer’s is its second with Merck & Co.’s former consumer products brands in its lineup.